Where does Vector Biomed's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vector Biomed's 1 recorded funding rounds.

Premier Alternatives

Vector Biomed

Other Pharmaceuticals and Biotechnology

Vector Biomed is a private other pharmaceuticals and biotechnology company. It has raised $15 million across 1 recorded round; the latest was a $15 million Series A in Jan 2023.

Last price · $/share

—

Implied valuation

—

Total raised

$15.0M

Last round

Early Stage VC (Series A)

Jan 2023

Cap table — not yet on record

Vector Biomed's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Vector Biomed with a free account

·Watch Vector Biomed: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Vector Biomed

Where does Vector Biomed's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vector Biomed's 1 recorded funding rounds.